Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
10/20/1999 | EP0740655B1 Metalloproteinase inhibitors |
10/20/1999 | EP0708651B1 Therapeutic agent |
10/20/1999 | CN1232501A Modified TIE-2 -receptor ligands |
10/20/1999 | CN1232457A 1,4-heterocyclic metalloprotease inhibitors |
10/20/1999 | CN1232456A PDE IV inhibiting 2-cyanoiminoimidazole derivs. |
10/20/1999 | CN1232451A Substd. cyclic amine metalloprotease inhibitors |
10/20/1999 | CN1232448A Vitamin D analogues |
10/20/1999 | CN1232447A Hydroxamic acid derivs. |
10/20/1999 | CN1232402A Method and compositions for immunomodulation |
10/20/1999 | CN1232399A Inhibitors of cysteine protease |
10/20/1999 | CN1045778C Novel chemical compounds having P.DE-IV inhibition activity |
10/20/1999 | CN1045777C Tetracyclic derivs. process of preparation and use |
10/20/1999 | CN1045767C Pyrazole derivs, processes for preparation thereof and pharmaceutical composition comprising same |
10/19/1999 | US5969184 Amide compounds |
10/19/1999 | US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils |
10/19/1999 | US5969093 Secreted proteins |
10/19/1999 | US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease |
10/19/1999 | US5968953 For side effect reduction |
10/19/1999 | US5968951 Benzenesulfonamide derivatives as bradykinin antagonists |
10/19/1999 | US5968948 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
10/19/1999 | US5968945 Immunotherapeutic agents |
10/19/1999 | US5968944 Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists |
10/19/1999 | US5968934 Treatment of pain, inflammation, migraines, emesis and postherapeutic neuralgia |
10/19/1999 | US5968927 Azepino-indole compounds; treatment of inflammatory, autoimmune and neurodegenerative diseases, prevention of ischemic injury |
10/19/1999 | US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
10/19/1999 | US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues |
10/19/1999 | US5968826 Antisense inhibition of integrin α4 expression |
10/19/1999 | US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
10/19/1999 | US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
10/19/1999 | US5968777 DNA encoding seryl t-RNA synthetase |
10/19/1999 | US5968547 Method of providing sustained analgesia with buprenorphine |
10/19/1999 | US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3 |
10/19/1999 | US5968482 Radiation resistant filters for light protection of cosmetics and drugs |
10/17/1999 | CA2269262A1 Substituted tricyclics |
10/17/1999 | CA2269256A1 Substituted tricyclics |
10/14/1999 | WO1999051742A2 Dadd, death activator death domain protein |
10/14/1999 | WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
10/14/1999 | WO1999051732A1 Secreted proteins and polynucleotides encoding them |
10/14/1999 | WO1999051626A2 Template associated npy y2-receptor agonists |
10/14/1999 | WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
10/14/1999 | WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR |
10/14/1999 | WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES |
10/14/1999 | WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
10/14/1999 | WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands |
10/14/1999 | WO1999051580A1 Pyrazole inhibitors of cytokine production |
10/14/1999 | WO1999051571A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
10/14/1999 | WO1999051569A1 Calcilytic compounds |
10/14/1999 | WO1999051273A1 Gelling ophthalmic compositions containing xanthan gum |
10/14/1999 | WO1999051241A1 Calcilytic compounds and method of use |
10/14/1999 | WO1999051213A2 The use of polyamines in the treatment of dermatological symptoms |
10/14/1999 | WO1999051212A2 Device for the transdermal delivery of diclofenac |
10/14/1999 | WO1999051185A2 Human galactosyl transferases |
10/14/1999 | WO1999044623A8 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
10/14/1999 | WO1999043809A3 Protease-activated receptor 4 and uses thereof |
10/14/1999 | WO1999042579A3 Caf1-related protein |
10/14/1999 | WO1999042075A3 Antibodies against human cd40 |
10/14/1999 | CA2327279A1 Calcilytic compounds |
10/14/1999 | CA2327188A1 Calcilytic compounds and method of use |
10/14/1999 | CA2327185A1 Pyrazole inhibitors of cytokine production |
10/14/1999 | CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists |
10/14/1999 | CA2326759A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
10/14/1999 | CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors |
10/14/1999 | CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor |
10/14/1999 | CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors |
10/14/1999 | CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands |
10/14/1999 | CA2326146A1 Template associated npy y2-receptor agonists |
10/14/1999 | CA2325523A1 Prodrugs of phosphorous-containing pharmaceuticals |
10/14/1999 | CA2325400A1 Device for the transdermal delivery of diclofenac |
10/14/1999 | CA2325339A1 Dadd, death activator death domain protein |
10/14/1999 | CA2325007A1 Human galactosyl transferases |
10/14/1999 | CA2324984A1 Secreted proteins and polynucleotides encoding them |
10/13/1999 | EP0949245A1 Process for alkylating hindered sulfonamides |
10/13/1999 | EP0948651A1 Recombinant n-smases and nucleic acids encoding same |
10/13/1999 | EP0948620A2 Secreted proteins and polynucleotides encoding them |
10/13/1999 | EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF |
10/13/1999 | EP0948544A1 Monovalent antibody fragments |
10/13/1999 | EP0948509A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
10/13/1999 | EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use |
10/13/1999 | EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
10/13/1999 | EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
10/13/1999 | EP0948353A1 Methods and compositions for immunomodulation |
10/13/1999 | EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
10/13/1999 | EP0948330A1 Il-8 receptor antagonists |
10/13/1999 | EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use |
10/13/1999 | EP0936912A4 Inhibitors of cysteine protease |
10/13/1999 | EP0783486B1 Novel prostaglandin synthase inhibitors |
10/13/1999 | EP0710233B1 Heteroaryl cycloalkenyl hydroxyureas |
10/13/1999 | EP0695185B1 Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions |
10/13/1999 | EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
10/13/1999 | CN1231700A Loxoprofen-containing preparation for external use |
10/13/1999 | CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
10/13/1999 | CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them |
10/13/1999 | CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease |
10/13/1999 | CN1231601A Oral delayed immediate release formulation and method of preparation therefor |
10/13/1999 | CN1231203A Ointment for rheumatic spur |
10/13/1999 | CN1231202A Traditional Chinese medicine preparation for treating colitis |
10/13/1999 | CN1045601C Novel quinuclidine derivatives and medicinal composition thereof |
10/13/1999 | CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
10/13/1999 | CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives |
10/12/1999 | US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis |